StreetInsider
Log in to your account:
Log in
Signup
Home
EPS Insider
Event Calendar
Conferences
Classic Site
Upgrade to SI Premium - Free Trial
JPMorgan Reiterates Overweight Rating on Abbott Labs (ABT)
October 16, 2024 4:12 PM
JPMorgan analyst Robbie Marcus reiterated an Overweight rating and $135.00 price target on Abbott Labs (NYSE: ABT)The analyst comments "We ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
Categories
Analyst Comments
Next Articles
TD Cowen Reiterates Buy Rating on Abbott Labs (ABT)
October 16, 2024 4:18 PM
Abbott Labs (ABT) PT Raised to $125 at Jefferies
October 16, 2024 4:04 PM
Abbott Labs (ABT) PT Raised to $130 at Stifel
October 16, 2024 3:21 PM
Abbott Labs (ABT) PT Raised to $128 at Evercore ISI
October 16, 2024 2:42 PM
Abbott Labs (ABT) PT Raised to $139 at BTIG
October 16, 2024 1:13 PM
CFRA Reiterates Buy Rating on Rio Tinto Plc. (RIO:LN) (RIO)
October 16, 2024 12:40 PM
Abbott narrows full-year financial guidance amid strength in medical device sales
October 16, 2024 8:07 AM
Form 8-K ABBOTT LABORATORIES For: Oct 16
October 16, 2024 7:38 AM
Abbott bumps up profit forecast on strong medical device sales
October 16, 2024 7:37 AM
Abbott (ABT) Tops Q3 EPS by 1c, Offers Guidance
October 16, 2024 7:32 AM
Abbott Reports Third-Quarter 2024 Results and Raises Midpoint of Full-Year EPS Guidance Range
October 16, 2024 7:30 AM
Abbott (ABT) October option implied volatility into quarter results
October 15, 2024 11:28 AM
Abbott (ABT) October 117 straddle priced for a move of 3.5% into the expected release before the b
October 15, 2024 1:34 AM
